131 related articles for article (PubMed ID: 21515969)
1. Tudor domain-containing protein 4 as a potential cancer/testis antigen in liver cancer.
Yoon H; Lee H; Kim HJ; You KT; Park YN; Kim H; Kim H
Tohoku J Exp Med; 2011 May; 224(1):41-6. PubMed ID: 21515969
[TBL] [Abstract][Full Text] [Related]
2. Expression of cancer-testis antigens in hepatocellular carcinoma.
Zhao L; Mou DC; Leng XS; Peng JR; Wang WX; Huang L; Li S; Zhu JY
World J Gastroenterol; 2004 Jul; 10(14):2034-8. PubMed ID: 15237429
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of two cancer-testis genes, FBXO39 and TDRD4, in breast cancer tissues and cell lines.
Seifi-Alan M; Shamsi R; Ghafouri-Fard S; Mirfakhraie R; Zare-Abdollahi D; Movafagh A; Modarressi MH; Kazemi G; Geranpayeh L; Najafi-Ashtiani M
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6625-9. PubMed ID: 24377578
[TBL] [Abstract][Full Text] [Related]
4. Cancer-testis Antigen OY-TES-1 Expression and Immunogenicity in Hepatocellular Carcinoma.
Luo B; Yun X; Li J; Fan R; Guo WW; Liu C; Lin YD; Ge YY; Zeng X; Bi SQ; Nong WX; Zhang QM; Xie XX
Curr Med Sci; 2020 Aug; 40(4):719-728. PubMed ID: 32862383
[TBL] [Abstract][Full Text] [Related]
5. Expressions of cancer-testis antigens in human hepatocellular carcinomas.
Chen CH; Chen GJ; Lee HS; Huang GT; Yang PM; Tsai LJ; Chen DS; Sheu JC
Cancer Lett; 2001 Mar; 164(2):189-95. PubMed ID: 11179834
[TBL] [Abstract][Full Text] [Related]
6. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma.
Lu Y; Wu LQ; Lü ZH; Wang XJ; Yang JY
Chin Med J (Engl); 2007 Jun; 120(12):1042-6. PubMed ID: 17637219
[TBL] [Abstract][Full Text] [Related]
7. Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma.
Wang M; Li J; Wang L; Chen X; Zhang Z; Yue D; Ping Y; Shi X; Huang L; Zhang T; Yang L; Zhao Y; Ma X; Li D; Fan Z; Zhao L; Tang Z; Zhai W; Zhang B; Zhang Y
Int J Clin Exp Pathol; 2015; 8(4):3513-28. PubMed ID: 26097535
[TBL] [Abstract][Full Text] [Related]
8. Comparisons for detecting NY-ESO-1 mRNA expression levels in hepatocellular carcinoma tissues.
Wang XY; Chen HS; Luo S; Zhang HH; Fei R; Cai J
Oncol Rep; 2009 Mar; 21(3):713-9. PubMed ID: 19212631
[TBL] [Abstract][Full Text] [Related]
9. Expression of cancer/testis (CT) antigens in Chinese hepatocellular carcinoma and its correlation with clinical parameters.
Peng JR; Chen HS; Mou DC; Cao J; Cong X; Qin LL; Wei L; Leng XS; Wang Y; Chen WF
Cancer Lett; 2005 Mar; 219(2):223-32. PubMed ID: 15723723
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma.
Grizzi F; Franceschini B; Hamrick C; Frezza EE; Cobos E; Chiriva-Internati M
J Transl Med; 2007 Jan; 5():3. PubMed ID: 17244360
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of the expression of FATE/BJ-HCC-2 antigen in normal and malignant tissues.
Yang XA; Dong XY; Qiao H; Wang YD; Peng JR; Li Y; Pang XW; Tian C; Chen WF
Lab Invest; 2005 Feb; 85(2):205-13. PubMed ID: 15580283
[TBL] [Abstract][Full Text] [Related]
12. Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: implications for immunotherapy in South African populations.
Dakshinamurthy AG; Ramesar R; Goldberg P; Blackburn JM
Biotechnol J; 2008 Nov; 3(11):1417-23. PubMed ID: 18956367
[TBL] [Abstract][Full Text] [Related]
13. Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis.
Kim H; Choi GH; Na DC; Ahn EY; Kim GI; Lee JE; Cho JY; Yoo JE; Choi JS; Park YN
Hepatology; 2011 Nov; 54(5):1707-17. PubMed ID: 22045674
[TBL] [Abstract][Full Text] [Related]
14. Expression of cancer-testis antigen (CTA) in tumor tissues and peripheral blood of Chinese patients with hepatocellular carcinoma.
Wu LQ; Lu Y; Wang XF; Lv ZH; Zhang B; Yang JY
Life Sci; 2006 Jul; 79(8):744-8. PubMed ID: 16546222
[TBL] [Abstract][Full Text] [Related]
15. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.
Patsenker E; Wilkens L; Banz V; Osterreicher CH; Weimann R; Eisele S; Keogh A; Stroka D; Zimmermann A; Stickel F
J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822
[TBL] [Abstract][Full Text] [Related]
16. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
[TBL] [Abstract][Full Text] [Related]
17. Expression of the midkine gene in human hepatocellular carcinomas.
Koide N; Hada H; Shinji T; Ujike K; Hirasaki S; Yumoto Y; Hanafusa T; Kadomatsu K; Muramatsu H; Muramatsu T; Tsuji T
Hepatogastroenterology; 1999; 46(30):3189-96. PubMed ID: 10626184
[TBL] [Abstract][Full Text] [Related]
18. Tudor-related proteins TDRD1/MTR-1, TDRD6 and TDRD7/TRAP: domain composition, intracellular localization, and function in male germ cells in mice.
Hosokawa M; Shoji M; Kitamura K; Tanaka T; Noce T; Chuma S; Nakatsuji N
Dev Biol; 2007 Jan; 301(1):38-52. PubMed ID: 17141210
[TBL] [Abstract][Full Text] [Related]
19. Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer.
Mischo A; Kubuschok B; Ertan K; Preuss KD; Romeike B; Regitz E; Schormann C; de Bruijn D; Wadle A; Neumann F; Schmidt W; Renner C; Pfreundschuh M
Int J Cancer; 2006 Feb; 118(3):696-703. PubMed ID: 16094643
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of cancer/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro.
Fu J; Luo B; Guo WW; Zhang QM; Shi L; Hu QP; Chen F; Xiao SW; Xie XX
Int J Clin Exp Pathol; 2015; 8(7):7786-97. PubMed ID: 26339343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
